Shares of Global Cord Blood Corp (CO) are trading 6% higher at a price of $2.5 at the time of this writing.

Global Cord Blood Corp has been trading between a 52-week high of $5.5 and a 52-week low of $2.1. The stock has a market cap of $304 Million.

Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.

Global Cord Blood wins injunction against Blue Ocean Structure Investment
Seeking Alpha 07-06-22

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
PR Newswire Asia (English) 07-06-22

Global Cord Blood Corporation Announces Fall In Q4 Income
Finanz Nachrichten 07-05-22

Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M
Seeking Alpha 07-05-22

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
PR Newswire Asia (English) 07-05-22